Mosaffa Sajedeh, Ahmadi Hanieh, Khakpai Fatemeh, Ebrahimi-Ghiri Mohaddeseh, Zarrindast Mohammad-Reza
Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, P.O.Box 13145-784, Tehran, Iran.
Cognitive and Neuroscience Research Center (CNRC), Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Psychopharmacology (Berl). 2021 Jan;238(1):259-269. doi: 10.1007/s00213-020-05679-6. Epub 2020 Nov 14.
Acute restraint stress (ARS) is an experimental paradigm used for the induction of rodent models of stress-produced neuropsychiatric disorders, such as depression and anxiety. β-carbolines and serotonin (5-HT) systems are involved in the modulation of depression and anxiety behaviors.
This study was designed to examine the effects of intracerebroventricular (i.c.v.) injection of cinanserin (5-HT2 receptor antagonist) on harmaline-induced responses on depression- and anxiety-like behaviors in the ARS mice.
For i.c.v. infusion, guide cannula was surgically implanted in the left lateral ventricle of mice. The ARS model was conducted via movement restraint at a period of 4 h. Depression- and anxiety-related behaviors were evaluated by forced swim test (FST) and elevated plus maze (EPM), respectively.
The results displayed that the ARS mice showed depressive- and anxiety-like responses. I.p. administration of different doses of harmaline (0.31, 0.625 and 1.25 mg/kg) or i.c.v. microinjection of cinanserin (1, 2.5, and 5 μg/mouse) blocked depression- and anxiogenic-like behaviors in the ARS mice. Furthermore, co-administration of harmaline (1.25 mg/kg; i.p.) and cinanserin (5 μg/mouse; i.c.v.) prevented the depression- and anxiogenic-like effects in the ARS mice. We found a synergistic antidepressant- and anxiolytic-like effects of harmaline and cinanserin in the ARS mice.
These results propose an interaction between harmaline and cinanserin to prevent depressive- and anxiogenic-like behaviors in the ARS mice.
急性束缚应激(ARS)是一种用于诱导应激所致神经精神疾病(如抑郁症和焦虑症)啮齿动物模型的实验范式。β-咔啉和血清素(5-HT)系统参与抑郁症和焦虑症行为的调节。
本研究旨在探讨脑室内(i.c.v.)注射辛那色林(5-HT2受体拮抗剂)对Harmaline诱导的ARS小鼠抑郁和焦虑样行为反应的影响。
对于脑室内输注,通过手术将引导套管植入小鼠左侧脑室。通过4小时的运动束缚建立ARS模型。分别通过强迫游泳试验(FST)和高架十字迷宫(EPM)评估与抑郁和焦虑相关的行为。
结果显示,ARS小鼠表现出抑郁和焦虑样反应。腹腔注射不同剂量的Harmaline(0.31、0.625和1.25mg/kg)或脑室内微量注射辛那色林(1、2.5和5μg/小鼠)可阻断ARS小鼠的抑郁和致焦虑样行为。此外,联合给予Harmaline(1.25mg/kg;腹腔注射)和辛那色林(5μg/小鼠;脑室内注射)可预防ARS小鼠的抑郁和致焦虑样作用。我们发现Harmaline和辛那色林在ARS小鼠中具有协同的抗抑郁和抗焦虑样作用。
这些结果表明Harmaline和辛那色林之间存在相互作用,可预防ARS小鼠的抑郁和致焦虑样行为。